Abstract:Osteoarthritic degeneration of cartilage is a major social health problem. Tissue engineering of cartilage using combinations of scaffold and mesenchymal stem cells (MSCs) is emerging as an alternative to existing treatment options such as microfracture, mosaicplasty, allograft, autologous chondrocyte implantation, or total joint replacement. Induction of chondrogenesis in high-density pellets of MSCs is generally attained by soluble exogenous TGF-β3 in culture media, which requires lengthy in vitro culture period during which pellets gain mechanical robustness. On the other hand, a growth factor delivering and a mechanically robust scaffold material that can accommodate chondroid pellets would enable rapid deployment of pellets after seeding. Delivery of the growth factor from the scaffold locally would drive the induction of chondrogenic differentiation in the postimplantation period. Therefore, we sought to develop a biomaterial formulation that will induce chondrogenesis in situ, and compared its performance to soluble delivery in vitro. In this vein, a heparin-conjugated mechanically robust collagen fabric was developed for sustained delivery of TGF-β3. The amount of conjugated heparin was varied to enhance the amount of TGF-β3 uptake and release from the scaffold. The results showed that the scaffold delivered TGF-β3 for up to 8 days of culture, which resulted in 15-fold increase in GAG production, and six-fold increase in collagen synthesis with respect to the No TGF-β3 group. The resulting matrix was cartilage like, in that type II collagen and aggrecan were positive in the spheroids. Enhanced chondrogenesis under in situ TGF-β3 administration resulted in a Young's modulus of ∼600 kPa. In most metrics, there were no significant differences between the soluble delivery group and in situ heparin-mediated delivery group. In conclusion, heparin-conjugated collagen scaffold developed in this study guides chondrogenic differentiation of hMSCs in a mechanically competent tissue construct, which showed potential to be used for cartilage tissue regeneration. Impact statement The most significant finding of this study was that sustained release of TGF-β3 from heparinized collagen scaffold had chondroinductive effect on pelleted human mesenchymal stem cells (hMSCs). The effect was comparable to that observed in hMSC pellets that were cultured in chondrogenic media supplemented with TGF-β3. The stiffness of scaffolds at the baseline was about 50% that of native cartilage and over 28 days the combined stiffness of pellet/scaffold complex converged to the stiffness of native cartilage. These data indicate that the scaffold system can generate a load-bearing cartilage-like tissue by using hMSCs pellets in a mechanically competent framework.

Incorporating Ptgf-Β1/calcium Phosphate Nanoparticles with Fibronectin into 3-Dimensional Collagen/chitosan Scaffolds: Efficient, Sustained Gene Delivery to Stem Cells for Chondrogenic Differentiation

Effective Gene Delivery to Mesenchymal Stem Cells Based on the Reverse Transfection and Three-Dimensional Cell Culture System

Dual Delivery for Stem Cell Differentiation Using Dexamethasone and Bfgf In/on Polymeric Microspheres As a Cell Carrier for Nucleus Pulposus Regeneration

Chondrogenesis of Mesenchymal Stem Cells through Local Release of TGF-β3 from Heparinized Collagen Biofabric

Silk Fibroin/cartilage Extracellular Matrix Scaffolds with Sequential Delivery of TGF-beta 3 for Chondrogenic Differentiation of Adipose-Derived Stem Cells

Enhanced MSC Chondrogenesis Following Delivery of TGF-β3 from Alginate Microspheres Within Hyaluronic Acid Hydrogels in Vitro and in Vivo.

Porous Chitosan Scaffolds With Embedded Hyaluronic Acid/Chitosan/Plasmid-Dna Nanoparticles Encoding Tgf-Beta 1 Induce Dna Controlled Release, Transfected Chondrocytes, And Promoted Cell Proliferation

Chondrogenic and Osteogenic Differentiations of Human Bone Marrow-Derived Mesenchymal Stem Cells on A Nanofibrous Scaffold with Designed Pore Network

Stem cell differentiation-related protein-loaded PLGA microspheres as a novel platform micro-typed scaffold for chondrogenesis

Non-viral Endostatin Plasmid Transfection of Mesenchymal Stem Cells Via Collagen Scaffolds.

Porous chitosan-gelatin scaffold containing plasmid DNA encoding transforming growth factor-β1 for chondrocytes proliferation

PREPARATION OF SULFATED CHITOSAN/POLYLYSINE/TRANSFORM GROWTH FACTOR-β1 NANOPARTICLES AND THEIR ABILITY TO INDUCE CHONDROGENESIS DIFFERENTIATION OF BMSCs

Sustained Pdgf-Bb Release from Phbhhx Loaded Nanoparticles in 3d Hydrogel/Stem Cell Model

Porous chitosan scaffolds with embedded hyaluronic acid/chitosan/plasmid-DNA nanoparticles encoding TGF-β1 induce DNA controlled release, transfected chondrocytes, and promoted cell proliferation.

Chondrogenic Commitment of Human Bone Marrow Mesenchymal Stem Cells in a Perfused Collagen Hydrogel Functionalized with hTGF-β1-Releasing PLGA Microcarrier

Chondrogenic Effect of Precartilaginous Stem Cells Following NLS-TAT Cell Penetrating Peptide-Assisted Transfection of Eukaryotic Htgfβ3

TGF‐β1 Gene‐engineered Mesenchymal Stem Cells Induce Rat Cartilage Regeneration Using Nonviral Gene Vector

Bone Marrow Mesenchymal Stem Cells Combined with Calcium Alginate Gel Modified by Htgf-Β1 for the Construction of Tissue-Engineered Cartilage in Three-Dimensional Conditions

Transfecting human transformation growth factor beta 3 gene into precartilaginous stem cells cultured in three-dimensional self-assembled peptide nanofiber scaffold of KLD-12

Chondrogenic Differentiation of Mesenchymal Stem Cells by Transforming Growth Factor-β1 Gene transfection with Liprofectamine

Novel Scaffold Containing Transforming Growth Factor-Beta 1 Dna For Cartilage Tissue Engineering